FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental Abbreviated New Drug Application for AMNESTEEM, a generic isotretinoin product from Mylan Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)